Oh SW - Search Results

1

Prognostic influence of Korean public medical insurance system on breast cancer patients.

Hwang KT, Ju YW, Kim YA, Kim J, Oh S, Jung J, Chai YJ, Choi IS, Oh SW. Hwang KT, et al. Among authors: oh sw, oh s. Ann Surg Treat Res. 2019 Feb;96(2):58-69. doi: 10.4174/astr.2019.96.2.58. Epub 2018 Jan 30. Ann Surg Treat Res. 2019. PMID: 30746353 Free PMC article.

2

Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.

Chai YJ, Yi JW, Oh SW, Kim YA, Yi KH, Kim JH, Lee KE. Chai YJ, et al. Among authors: oh sw. Surgery. 2017 Jan;161(1):188-194. doi: 10.1016/j.surg.2016.04.050. Epub 2016 Nov 11. Surgery. 2017. PMID: 27842912

3

The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer.

Hwang KT, Kim YA, Kim J, Chu AJ, Chang JH, Oh SW, Hwang KR, Chai YJ. Hwang KT, et al. Among authors: oh sw. Breast Cancer Res Treat. 2017 May;163(1):71-82. doi: 10.1007/s10549-017-4153-4. Epub 2017 Feb 13. Breast Cancer Res Treat. 2017. PMID: 28194538

4

Adenine Nucleotide Translocase 2 as an Enzyme Related to [¹⁸F] FDG Accumulation in Various Cancers.

Lee CH, Kim MJ, Lee HH, Paeng JC, Park YJ, Oh SW, Chai YJ, Kim YA, Cheon GJ, Kang KW, Youn H, Chung JK. Lee CH, et al. Among authors: oh sw. Mol Imaging Biol. 2019 Aug;21(4):722-730. doi: 10.1007/s11307-018-1268-x. Mol Imaging Biol. 2019. PMID: 30225759

5

Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, ¹⁸F-rhPSMA-7, in Patients with Prostate Cancer.

Oh SW, Wurzer A, Teoh EJ, Oh S, Langbein T, Krönke M, Herz M, Kropf S, Wester HJ, Weber WA, Eiber M. Oh SW, et al. Among authors: oh s. J Nucl Med. 2020 May;61(5):702-709. doi: 10.2967/jnumed.119.234609. Epub 2019 Dec 13. J Nucl Med. 2020. PMID: 31836686 Free PMC article.

6

Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer.

Ha S, Oh SW, Kim YK, Koo do H, Jung YH, Yi KH, Chung JK. Ha S, et al. Among authors: oh sw. J Korean Med Sci. 2015 Jul;30(7):876-81. doi: 10.3346/jkms.2015.30.7.876. Epub 2015 Jun 10. J Korean Med Sci. 2015. PMID: 26130949 Free PMC article.

7

Prognostic value of FDG PET/CT during radiotherapy in head and neck cancer patients.

Kim S, Oh S, Kim JS, Kim YK, Kim KH, Oh DH, Lee DH, Jeong WJ, Jung YH. Kim S, et al. Radiat Oncol J. 2018 Jun;36(2):95-102. doi: 10.3857/roj.2017.00577. Epub 2018 Jun 29. Radiat Oncol J. 2018. PMID: 29983029 Free PMC article.

8

Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer.

Oh SW, Moon SH, Park DJ, Cho BY, Jung KC, Lee DS, Chung JK. Oh SW, et al. Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1798-805. doi: 10.1007/s00259-011-1849-2. Epub 2011 Jun 23. Eur J Nucl Med Mol Imaging. 2011. PMID: 21698415

9

Incremental Prognostic Value of Brachial-Ankle Pulse Wave Velocity to Single-Photon Emission Computed Tomography in Patients with Suspected Coronary Artery Disease.

Lee HS, Kim HL, Kim H, Hwang D, Choi HM, Oh SW, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. Lee HS, et al. Among authors: oh sw. J Atheroscler Thromb. 2015;22(10):1040-50. doi: 10.5551/jat.29918. Epub 2015 Aug 3. J Atheroscler Thromb. 2015. PMID: 26235347 Free article.

10

Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study.

Kwon SY, Lee SW, Kong EJ, Kim K, Kim BI, Kim J, Kim H, Park SH, Park J, Park HL, Oh SW, Won KS, Ryu YH, Yoon JK, Lee SJ, Lee JJ, Chong A, Jeong YJ, Jeong JH, Cho YS, Cho A, Cheon GJ, Choi EK, Hwang JP, Bae SK; Korean Society of Nuclear Medicine (KSNM) Thyroid Cancer Clinical Trial Network (CTN) Retrospective Cohort Study Group. Kwon SY, et al. Among authors: oh sw. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):561-571. doi: 10.1007/s00259-019-04634-8. Epub 2019 Dec 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 31820047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

572 results

Search Page